Partnering with Genvira

At Genvira, we believe that solving the toughest challenges in viral vector engineering requires collaboration. We actively partner with biotech inovators, academic groups, and indrustry leaders to accelerate the development of transofrmative therapies and vaccines.

Out partnership models

• Research collaborations — Join discovery and platform development to exploore new viral vector designs and applications.
• In-/Out-licensing — Flexible licensing of our proprietary viral engineering technologies or aceess to external innovations that complement out platform.
• Joint & Co-Development — Shared development programs to advance therapies from concept to clinic.
• Strategic Partnerships & Others — Tailored models to support unique business and scientific opportunities.

Why Partner with us?

• Deep expertise in viral engineering, payload design, and stability optimization
• Customizable Vectors for Gene therapy, vaccines, and immuno-oncology
• Collaborative Approach with a track record of working across biotech, pharma, and acadamia

Contact

We welcome inquiries from potential partners. Please reach out to us at bit99d@genienvira.com